drugset / Trial / NCT00024323

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00024323

Phase 1 Completed Vion Pharmaceuticals
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining 3-AP with cisplatin in treating patients who have advanced cancer.

Timeline

Start
2001-03
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Triapine Small molecule 96 mg/m2 Intravenous